Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hologic Inc
(NQ:
HOLX
)
74.51
-0.27 (-0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hologic Inc
< Previous
1
2
3
4
5
Next >
3 Top Analyst Picks Worth Your Attention Now
July 17, 2023
These top analyst picks, offering robust upside ahead, represent a beacon amidst the stock market chaos at this time.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
July 14, 2023
Via
Benzinga
Expert Ratings for Hologic
June 15, 2023
Via
Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
June 02, 2023
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.
Via
Benzinga
What 9 Analyst Ratings Have To Say About Hologic
May 03, 2023
Via
Benzinga
Earnings Preview For Hologic
April 28, 2023
Via
Benzinga
Cowen & Co. Maintains Outperform Rating for Hologic: Here's What You Need To Know
February 02, 2023
Via
Benzinga
Time To Play Small Cap Life Science Stocks
May 15, 2023
The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.
Via
Talk Markets
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
Earnings Outlook For Hologic
January 31, 2023
Via
Benzinga
Where Hologic Stands With Analysts
January 24, 2023
Via
Benzinga
Analyst Expectations for Hologic's Future
January 06, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On Hologic's Chart?
December 22, 2022
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
7 Analysts Have This to Say About Hologic
December 07, 2022
Via
Benzinga
Analyst Ratings for Hologic
December 07, 2022
Via
Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
April 01, 2023
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...
Via
Talk Markets
SMID Cap Life Science Update: Are You An Investor Or Trader?
February 20, 2023
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.
Via
Talk Markets
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Via
Talk Markets
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
January 13, 2023
Sharp Tesla price cuts and some notable earnings were in focus.
Via
Investor's Business Daily
Where Hologic Stands With Analysts
November 01, 2022
Within the last quarter, Hologic (NASDAQ:HOLX) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Hologic
November 01, 2022
Hologic (NASDAQ:HOLX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.
Via
Benzinga
What's Going On With Hologic Shares Today?
January 09, 2023
Hologic, Inc. (NASDAQ: HOLX) shares are trading higher today after the company reported preliminary first-quarter revenue results.
Via
Benzinga
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Topics
Death
Exposures
Death
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 13, 2022
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX<
Via
Benzinga
Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 14, 2022
Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options.
Via
Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
November 02, 2022
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.